Multiple and Recurrent Squamous Cell Carcinoma of the Oral Cavity After Graft-Versus-Host Disease

被引:10
|
作者
Weng, Xiuhong [1 ]
Xing, Yuzhen [1 ]
Cheng, Bo [1 ]
机构
[1] Huazhong Univ Sci & Technol, Dept Stomatol, Wuhan Union Hosp, Tongji Med Coll, 1277 Jiefang Ave, Wuhan 430022, Hubei, Peoples R China
基金
中国国家自然科学基金;
关键词
TRADITIONAL CHINESE MEDICINE; LONG-TERM SURVIVORS; FANCONI-ANEMIA; SOLID CANCERS; TRANSPLANTATION; THERAPY; HEAD; DYSPLASIA;
D O I
10.1016/j.joms.2017.02.012
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Oral squamous cell carcinoma (OSCC) is one of the most common secondary solid tumors in patients who have undergone hematopoietic stem cell transplantation (HSCT). However, according to previous reports, multiple and recurrent OSCC is very rare. The presented case shows the susceptibility to the development of secondary malignancies, particularly oral cancer, of patients who present with chronic graft-versus-host disease after HSCT. OSCC after HSCT appears to be more invasive and has a tendency to recur, with a poor prognosis. Therefore, regular and thorough evaluations of the oral mucosa are recommended for all patients who undergo bone marrow transplantation and have chronic graft-versus-host disease. (C) 2017 American Association of Oral and Maxillofacial Surgeons
引用
收藏
页码:1899 / 1905
页数:7
相关论文
共 50 条
  • [31] Metastasiertes Plattenepithelkarzinom auf einem Ulkus bei Graft-versus-Host-Disease nach allogener StammzelltransplantationMetastatic squamous cell carcinoma on an ulcer in graft-versus-host disease after allogeneic stem cell transplantation
    S. Hobelsberger
    F. Meier
    S. Beissert
    S. Abraham
    Die Dermatologie, 2022, 73 (9) : 722 - 726
  • [32] Oral chronic graft-versus-host disease in pediatric patients after hematopoietic stem cell transplantation
    Treister, NS
    Woo, SB
    O'Holleran, EW
    Lehmann, LE
    Parsons, SK
    Guinan, EC
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (09) : 721 - 731
  • [33] Recurrent nephrotic syndrome associated with graft-versus-host disease
    Ikee, R
    Yamamoto, K
    Kushiyama, T
    Imakiire, T
    Suzuki, S
    Miura, S
    BONE MARROW TRANSPLANTATION, 2004, 34 (11) : 1005 - 1006
  • [34] Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease
    Wolff, Daniel
    Cutler, Corey
    Lee, Stephanie J.
    Pusic, Iskra
    Bittencourt, Henrique
    White, Jennifer
    Hamadani, Mehdi
    Arai, Sally
    Salhotra, Amandeep
    Perez-Simon, Jose A.
    Alousi, Amin
    Choe, Hannah
    Kwon, Mi
    Bermudez, Arancha
    Kim, Inho
    Socie, Gerard
    Chhabra, Saurabh
    Radojcic, Vedran
    O'Toole, Timothy
    Tian, Chuan
    Ordentlich, Peter
    Defilipp, Zachariah
    Kitko, Carrie L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (11): : 1002 - 1014
  • [35] Recurrent nephrotic syndrome associated with graft-versus-host disease
    R Ikee
    K Yamamoto
    T Kushiyama
    T Imakiire
    S Suzuki
    S Miura
    Bone Marrow Transplantation, 2004, 34 : 1005 - 1006
  • [36] GRAFT-VERSUS-HOST DISEASE
    SVEDENTSOV, YP
    SHARYGIN, SL
    EPIFANOV, NS
    MATVEEV, GA
    KLINICHESKAYA MEDITSINA, 1993, 71 (05): : 19 - 23
  • [37] Graft-versus-Host Disease
    Choi, S.
    Reddy, P.
    PANMINERVA MEDICA, 2010, 52 (02) : 111 - 124
  • [38] GRAFT-VERSUS-HOST DISEASE
    DEEG, HJ
    TRANSFUSION SCIENCE, 1994, 15 (03): : 187 - 188
  • [39] GRAFT-VERSUS-HOST DISEASE
    VOGELSANG, GB
    WAGNER, JE
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1990, 4 (03) : 625 - 639
  • [40] GRAFT-VERSUS-HOST DISEASE OR GRAFT-VERSUS-HOST LIKE SYNDROME - RESPONSE
    YEAGER, AM
    BLOOD, 1992, 80 (11) : 2949 - 2950